AzTrials
AzTrials

Cancer of ProstatePROSTATE SSINCT01639859

Assessment of Supersonic Imagine Aixplorer for the Detection and Localisation of Prostate Cancer Foci

A study testing Elastography in people with Cancer of Prostate, run by Hospices Civils de Lyon at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The primary aim of the study is to assess the elasticity (Young's modulus) of cancerous tumor foci, of normal peripheral zone, and of normal transition zone in the prostate. Images obtained with the Supersonic Imagine Aixplorer scanner prior to radical prostatectomy are compared to whole-mount histology. Read more about this study

Who is it for?
Ages 18 years and older, men only
Conditions the study is for
Cancer of Prostate
What is being tested?
Elastography
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteFrance
Study dates
Oct 2011to Aug 2013
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Men only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patient over 18 years old, with prostate cancer and scheduled for radical prostatectomy

Who cannot join

  • Medical history of prostate surgery or radiotherapy of prostate
  • Medical history of abdominal perinéanal amputation or whole of state which prevent to use endorectal probe

Trial locations and contacts

1 site in 1 country.

France1 site
  • Service de Radiologie, Pavillon P Radio, Hôpital Edouard Herriot

    Lyon, LYON, 69 437

Other trials in France

About this study

The primary aim of the study is to assess the elasticity (Young's modulus) of cancerous tumor foci, of normal peripheral zone, and of normal transition zone in the prostate. Images obtained with the Supersonic Imagine Aixplorer scanner prior to radical prostatectomy are compared to whole-mount histology.

Being tested
Elastography
Keywords
prostate cancer, elastography, elasticity
Medical subject headings
Prostatic Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ElastographyOther

    Also called Supersonic Imagine Aixplorer scanner

    The elastography in vivo will be performed before the prostatectomy. The elastography ex vivo will be performed after radical prostatectomy.

Study groups in NCT01639859
Study groupRoleWhat they receive
ElastographyExperimentalNot described
Receives: Other: Elastography

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Young's modulus(kPa) of cancerous tumor foci

    Measured: 2 years

  2. Young's modulus(kPa) of normal peripheral zone

    Measured: 2 years

  3. Young's modulus(kPa) of normal transition zone

    Measured: 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jul 2012 (estimated)
  2. Study startOct 2011
  3. Primary completionOct 2012
  4. Study completionAug 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01639859
Sponsor's protocol ID
2011.658
Acronym
PROSTATE SSI
Status last verified
Jan 2025
First submitted
22 Jun 2012
Last updated
10 Jan 2025
Results posted
No
Data monitoring committee
No

Publications

  • Rouviere O, Melodelima C, Hoang Dinh A, Bratan F, Pagnoux G, Sanzalone T, Crouzet S, Colombel M, Mege-Lechevallier F, Souchon R. Stiffness of benign and malignant prostate tissue measured by shear-wave elastography: a preliminary study. Eur Radiol. 2017 May;27(5):1858-1866. doi: 10.1007/s00330-016-4534-9. Epub 2016 Aug 23.

    PubMed 27553936

Questions about this trial

What is this clinical trial studying?

A study testing Elastography in people with Cancer of Prostate, run by Hospices Civils de Lyon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Young's modulus(kPa) of cancerous tumor foci (time frame: 2 years). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01639859, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jan 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in